Automated Insulin Dosing via Glucose Aggregation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Manual calculation of insulin doses for diabetes management is prone to human error, and existing protocols can be complex and conflicting, making it difficult for patients, especially young children and the elderly, to accurately administer insulin doses.

Innovation Solution

A system and method for determining recommended insulin dosages using data processing hardware that aggregates blood glucose measurements from a glucometer, calculates representative aggregate measurements, and adjusts dosages based on previous data to provide accurate and personalized insulin recommendations, transmitted to a portable device for administration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If manual calculation methods are used for insulin dosing, then flexibility in administration is maintained, but human error increases and dosing accuracy decreases

Engineering Contradiction:
Improvedosing accuracyVSAvoidoperation complexity
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent replaces manual mechanical calculation methods with an automated electronic computing system. The insulin dosage calculation is performed by a processor that receives blood glucose data and automatically computes the recommended dosage, eliminating human calculation errors while providing clear display instructions for patients.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system enables patients to independently obtain accurate insulin dosing recommendations through the portable device without requiring manual calculation skills. The device self-processes blood glucose data and generates dosing instructions that patients can directly follow, making the system both reliable and easy to operate.

Inventive Principle:
Principle #25Self-service

2Adaptability or versatility

If multiple institutional protocols are used for insulin calculation, then various clinical scenarios are covered, but protocol conflicts increase and calculation complexity increases

Engineering Contradiction:
Improveprotocol coverageVSAvoidcalculation system complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The computing device is designed to implement multiple insulin dosage calculation protocols within a single system. The processor can select and apply appropriate protocols based on patient-specific parameters and clinical scenarios, providing versatile coverage while maintaining a unified, manageable interface for the user.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Measurement precision

If complex calculation protocols are implemented, then dosing precision is improved, but patient understanding and ease of use deteriorates

Engineering Contradiction:
Improvedosage calculation precisionVSAvoidpatient comprehension
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The portable computing device serves as an intermediary between complex calculation protocols and the patient. It performs the sophisticated dosage calculations internally using multiple protocols and protocols selection logic, then presents simplified, easy-to-understand dosing instructions on the display, bridging the gap between precision and comprehensibility.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS12023127B2Subcutaneous outpatient management
Publication Date: 2024.07.02 GLYTEC LLC
  • US12023127B2 patent drawing
  • US12023127B2 patent drawing
  • US12023127B2 patent drawing

AI summary

A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining glucose data of the patient, aggregating glucose measurements to determine a representative aggregate glucose measurement associated with at least one scheduled glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to administration device associated with the patient.